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Objectives We hypothesize that increasing high-density lipoprotein cholesterol (HDL-C) shortens cardiac repolarization.
Background HDL-C is inversely associated with sudden death. The relation between HDL-C and repolarization of the heart is
unexplored.
Methods HDL-C was elevated with reconstituted high-density lipoprotein (rHDL). Cardiac repolarization was studied by re-
cording cardiac transmembrane potentials with the patch clamp technique from isolated rabbit cardiomyocytes
that were superfused with rHDL. Infusions with rHDL (40 mg/kg body weight) were performed in dyslipidemic
patients and healthy volunteers. Electrocardiograms were recorded to assess cardiac repolarization before and
24 h after infusion with rHDL.
Results rHDL as well as purified human apolipoprotein AI shortened repolarization of isolated rabbit cardiomyocytes by
25% (p  0.05). rHDL infusion shortened the heart rate-corrected QT interval on surface electrocardiograms in
all participants (p  0.001).
Conclusions rHDL shortens cardiac repolarization. These data provide evidence for a novel mechanism of HDL infusion that
may contribute to reduction of sudden cardiac death. (J Am Coll Cardiol 2011;58:40–4) © 2011 by the
American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.11.072Low plasma levels of high-density lipoprotein cholesterol
(HDL-C) or apolipoprotein (apo) A-I are independent
predictors of increased cardiovascular morbidity and mor-
tality (1). The inverse relation between these parameters has
thus far been largely attributed to cholesterol depletion of
the atherosclerotic plaque (2,3), the first step in reverse
cholesterol transport (4). Cardiovascular death, however, is
often preceded by ventricular tachyarrhythmias. Prolonga-
tion of the cardiac repolarization time, which has been
shown to predict sudden cardiac death (5–7), often under-
lies these rhythm disturbances. Elevated cholesterol has,
besides its relation with accelerated atherogenesis, also been
associated with the occurrence of ventricular fibrillation
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out to study whether high-density lipoprotein (HDL) exerts
a direct effect on the cardiac repolarization, specifically
whether increasing HDL shortens cardiac repolarization
and the QT interval. To test the hypothesis, we studied the
effects of reconstituted high-density lipoprotein (rHDL) in
vitro and in dyslipidemic patients.
See page 45
Methods
Cellular study. This study was approved by the local
institutional ethical committee. Animal care and handling
conformed to the Guide for Care and Use of Laboratory
Animals published by the U.S. National Institutes of Health
(NIH publication no. 85-23, revised 1996).
We used hearts from healthy New Zealand White male
rabbits (n  3) to isolate midmural left ventricular cardio-
myocytes as described (9). Transmembrane potentials were
recorded using the amphotericin-B perforated patch-clamp
technique at 37°C. Action potentials were elicited at 0.5 to
4 Hz by 3-ms, 1.5 threshold current pulses through the
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June 28, 2011:40–4 HDL Shortens Cardiac Repolarizationpatch pipette. Recordings were low-pass filtered with a
cutoff frequency of 5 kHz, digitized 10 kHz, and corrected
for liquid junction potentials (10). Bath solution contained
Tyrode’s solution (in mmol/l): NaCl 140, KCl 5.4, CaCl2
1.0, glucose 5.5, HEPES 5.0; pH 7.4, pipette solution
contained (in mmol/l): K-gluconate 125, KCl 20, NaCl 5,
HEPES 10, amphotericin-B 2.2; pH 7.2 (KOH). Data
Figure 1 rHDL Shortens the Cardiac Action Potential
(A) The ventricular cardiac action potential duration is shortened after reconstitute
cardiac action potential returns to its original shape and duration (arrow 3). Inset
sponding signal on the electrocardiogram (ECG). (B) Averaged data on action pote
cytes from 3 hearts) and the action potential amplitude. Action potential amplitud
(C) Frequency dependence of rHDL on the cardiac action potential duration. (D) D
APD after and before rHDL superfusion). The arrow points to the concentration u
Information on Healthy Volunteersand Dyslipidemic PatientsTable 1 I form io n Healthy Volunteersand Dyslipidemic Patients
Patient Characteristics
Age (yrs) Sex
Body
Weight (kg) Mutation
Healthy volunteers 31 M 82 —
29 M 80 —
25 M 100 —
apo A-I/ patients 63 M 77 L178P
66 F 59 L178P
ABCA1/patients 65 F 88 Q1038X/N1800H
44 F 60 L1056P/L1056P
LCAT/ patients 43 M 83 R268H
54 M 105 T107X
58 M 84 I202T
47 M 89 T147I/V309M
31 F 74 V333M
ABCA1  ATP binding cassette transporter A1; apo  apolipoprotein; LCAT  lecithin-cholesterol
cyltransferase.90acquisition and analysis were ac-
complished using custom soft-
ware.
Reconstituted HDL consisting
of apo A-I isolated from human
plasma reconstituted with soy phos-
phatidylcholine (CSL111, CLS
Behring AG, Bern, Switzerland)
was applied at a concentration of
50 g/ml until steady state was
eached (approximately 5 min).
tudy participants. The insti-
utional internal review board
pproved the study, and all participants gave written in-
ormed consent. rHDL was infused in 12 individuals with a
ide range of HDL-C plasma and apo A-I concentrations,
onsisting of healthy volunteers (n  3), heterozygotes for
utations in either apo A-I (n  2) or lecithin-cholesterol
cyltransferase (LCAT) (n  5), or homozygotes for mu-
ations in ATP binding cassette transporter A1 (ABCA1)
n  2). Table 1 provides information on the participants.
n this nonrandomized open-label study, rHDL was infused
t a dose of 40 mg/kg bodyweight over a 4-h period without
dverse effects. Electrocardiograms (ECGs) and were re-
orded before and 24 h after infusion. Blood was drawn
efore and 24 h after infusion. Total plasma cholesterol,
-density lipoprotein (rHDL) superfusion (arrow 1 vs. arrow 2). Upon washout, the
matic representation of the ventricular action potential duration and the corre-
uration (APD) at 20%, 50%, and 90% repolarization at 1 Hz (n  10 cardiomyo-
ates plateau potential at 1 Hz, and the Vmax is the maximal upstroke velocity.
sponse relation between rHDL and the APD90 (expressed as a ratio between the
p  0.05.
Abbreviations
and Acronyms
apo  apolipoprotein
HDL  high-density
lipoprotein
HDL-C  high-density
lipoprotein cholesterol
QTc  QT interval
corrected for heart rate
rHDL  reconstituted high
density lipoproteind high
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HDL Shortens Cardiac Repolarization June 28, 2011:40–4triglycerides, HDL-C, low-density lipoprotein cholesterol,
apo B, apo A-I, and apo A-II levels were measured with
commercial kits (Wako, Neuss, Germany, and Randox,
Crumlin, United Kingdom) on a Cobas Mira autoanalyzer.
QT intervals were measured at the intersect of the tangent
of the end of the T-wave with the baseline in 3 consecutive
beats in lead V5 by 2 independent researchers, and corrected
for heart rate using Bazett’s formula (QTc) (11). In 3
LCAT-patients, saline was infused as a control.
Statistical analysis. Data are presented as mean  SEM
and were analyzed using a paired t-test or a signed rank test
(p  0.05 is considered statistically significant).
Results
Cellular study. Figure 1A shows superimposed examples
of a cardiac action potential under control conditions (arrow 1),
Figure 2 Infusion of rHDL Shortens QTc Intervals in Humans
(A) Averaged apo A-I levels  SEM before and 24 h after rHDL infusion (all subjec
sion (all subjects). Bottom panel: Example of a complex of an ECG recording befo
before and 24 h after rHDL infusion. (D) The individual corresponding QTc duration
tions as in Figure 1.in the presence of rHDL (arrow 2), and after a washout ofrHDL (arrow 3) at a pacing cycle length of 1 s. Figure 1B
demonstrates a statistically significant shortening of the
action potential duration at 20%, 50%, and 90% of repolar-
ization after 5 min of superfusion (10 myocytes obtained
from 3 hearts). The plateau amplitude (defined at action
potential amplitude measured 60 ms following the upstroke)
was significantly decreased (p  0.05, paired t-test), but the
action potential upstroke velocity (Vmax) remained unaltered
(Fig. 1B). The maximum diastolic potential was also un-
changed (not shown). The action potential shortening was
observed over the entire range of tested pacing cycle lengths
(0.5 to 4 Hz) (Fig. 1C). For the experiment, we used rHDL
at the lowest concentration with a maximum effect (arrow,
Fig. 1D). Superfusion with purified apo A-I (50 g/ml, the
lowest but still physiological apo A-I concentration ob-
served in human plasma) caused a decrease of the APD90 (at
1 Hz) from 236  14.6 to 205  17.2 (p  0.05, paired
) Top panel: Averaged QTc durations  SEM before and 24 h after rHDL infu-
ck line) and after (dotted black line) rHDL infusion. (C) Individual apo A-I levels
 apolipoprotein; QTc  QT interval corrected for heart rate; other abbrevia-ts). (B
re (bla
s. apot-test) similar to the rHDL superfusion.
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June 28, 2011:40–4 HDL Shortens Cardiac RepolarizationHuman study. Upon rHDL infusion, baseline apo A-I
levels rose from 87  13.0 mg/dl to 107  12.0 mg/dl (p 
.001) (Fig. 2A), and QTc decreased from 394  8.7 ms to
71  7.5 ms (p  0.001) (Fig. 2B). rHDL infusion
esulted in a similar effect on QTc in all individuals studied
ndependent of baseline apo A-I/HDL-C values (individual
ata in Figs. 2C and 2D). Infusion with vehicle (saline
olution) in 3 LCAT patients did not affect QTc (before
nfusion: 391  8.0 ms and 392  6.3 ms following
nfusion). These data indicate that there are no time- and
nfusion-dependent effects related to the infusion procedure.
Other lipid parameters are summarized in Table 2.
DL-C levels rose and total cholesterol, LDL-c, and apo B
evels decreased following the rHDL infusion in all subjects.
eart rate was significantly decreased following rHDL
nfusion in all participants. There were no differences in any
f the other electrocardiographic parameters.
iscussion
his study shows for the first time a direct relation between
HDL and cardiac repolarization. Reconstituted HDL
hortens the action potential duration in isolated cardiomy-
cytes over a wide range of pacing frequencies in vitro.
ecause pure apo A-I resulted in identical effects, it is
nlikely that (bioactive) phospholipids in the rHDL prep-
ration contributed to this beneficial effect. Reconstituted
DL infusion also shortened the QTc interval in 12
articipants independent of baseline apo A-I levels. Inter-
stingly, similar in vivo effects were observed in patients
ith complete ABCA1 deficiency, indicating that ABCA1-
ediated lipidation of apo A-I is apparently not required for
he observed effect. The difference in heart rate following the
Lipid Profiles and ECG ParametersBefore and 24 h After rHDL InfusionTable 2 Lipi Profiles nd ECG ParametersBefore and 24 h After rHDL Infusion
Before rHDL
Infusion
24 h After rHDL
Infusion
p ValueLipid Parameters in All Subjects
Total cholesterol, mmol/l 4.2 0.39 3.8 0.32 0.011
HDL-C, mmol/l 0.7 0.14 0.8 0.13 0.001
LDL-C, mmol/l 3.1 0.29 2.7 0.22 0.005
Triglycerides, mmol/l 1.5 0.29 1.5 0.22 NS
apo A-I, mg/dl 87 13.0 107 12.0 0.001
apo B, mg/dl 117 10.3 100 7.7 0.001
ECG Parameters in All Subjects
PR interval, ms 155 8.2 164 7.9 NS
QRS time, ms 90 3.2 90 3.1 NS
QT, ms 384 8.7 385 8.0 NS
Heart rate, beats/min 64 3.1 56 2.5 0.002
QTc, ms 394 8.7 371 7.5 0.001
Values are mean  SEM. p values are calculated for differences between before and 24 h after
rHDL infusion in all subjects.
ECG  electrocardiogram; HDL-C  high-density lipoprotein cholesterol; LDL-C  low-density
ipoprotein cholesterol; QTc  QT interval corrected for heart rate; rHDL  reconstituted high-
ensity lipoprotein.HDL infusion in the participants may have been due to directlectrophysiological effects of rHDL on the sinus node or may
ave been due to other variables (stressors). We therefore
orrected the QT interval using the Bazett’s formula. Although
his procedure may have underestimated the QT interval at
lower heart rates, the recapitulation of these results in the
nimal study in which we were able to reconstruct the entire
estitution curve, without the need for rate correction, demon-
trates that this has not played a major role.
The applied rHDL dose in humans is identical to that
sed in previous studies and was well tolerated (12,13).
ecause infusion of phosphatidylcholine as a “vehicle-
ontrol” is potentially toxic and ethically not justified, we
ave used infusion of saline as a control (3). A potential role
f phosphatidylcholine cannot be ruled out.
The newly identified effect of rHDL may have clinical
mplications in that QTc prolongation is associated with an
ncreased risk of ventricular arrhythmias and is also reported as
n independent risk factor for sudden cardiac death (6,14–16).
econstituted HDL infusions have been successfully used in
oth animal studies and in clinical trials to elevate apo A-I and
DL-C levels (17,18), but the long-term effect of this inter-
ention is unknown, and its feasibility as an antiarrhythmic
rug in clinical practice remains to be determined. The current
ata underscore the need for future, larger, randomized clinical
rials into the antiarrhythmic effect of apo AI–elevating strat-
gies (19) in high-risk patients.
onclusions
hese data suggest a new role of HDL in the prevention of
udden arrhythmic death.
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